Let's hope that the goal of all posters its to contribute to the common pool of knowledge.
No one should mind whether contributions are positive or negative so as as they are reasonably formed and posted in good faith.
In my view, NUH is following the relatively well worn path of many start up, innovative companies. The perennial conflict between inadequate capital resources, hype, incumbent player response and shareholder hope and despair is typical.
l concede no knowledge on the destiny of Nuheara as it muddled its way through these early years. We gave moved on from consumer electronics unappreciative of hearing enhancement technology to the more technically demanding hearing impairment market, having burned through a fair amount of capital in that learning.
For me, the NHS win was and is the game changing moment, yet even that has hairs on it and may not be the saviour of the company. Business is complicated.
Management has by and large been strong and certainly well intentioned. Many here including myself have been critical of certain aspects of communication but ultimately they are playing with small money in a big money game.
l think by early 2020, the results of the company will speak for themselves. It will either have traction in the market and cash flow to grow or leave us to ponder the possibilities of what could have been. We all need to be prepared for a sink or swim outcome.
Until then, being Easter, my faith takes me to a more spiritual and philosophical place where the ASX takes a back seat.
GLTA and to those who may care, Happy Easter.
NUH Price at posting:
7.6¢ Sentiment: Hold Disclosure: Held
(20min delay)